Aaron M. Klein

Mr. Klein's recent representations include:

• Acquaventure Holdings in its acquisition of Constructora Panorama.
• Affiliates of Ampio Pharmaceuticals in their acquisition of Rosewind.
• Ampersand Capital Partners portfolio company, Innovative Food Processors, Inc., in its sale to Balchem Corporation.
• Ascension Health Ventures growth equity investment in Voalte.
• Bain Capital Ventures in its growth equity investment in AvidXchange.
• Bain Capital Ventures in its growth equity investment in Novus.
• Bain Capital Ventures in its growth equity investment in Flow Commerce.
• Berhman Capital in its acquisition of Paragon.
• BirdDog Solutions in its sale to a subsidiary of Transportation Insight.
• Brammer Bio in connection with a recapitalization.
• Bregal Sagemount in its growth equity investment in Align Financial Group.
• DiscoverOrg in its acquisition of Rain King Software.
• DSI Renal in its tender offer and merger with U.S. Renal Care, Inc.
• DST Global in its growth equity investment in Deliveroo.
• DST Global in its growth equity investment in NuBank.
• Frazier Healthcare in its acquisition of Vein Clinics of America.
• Frazier Healthcare portfolio company, Matrix Medical, in its acquisition of LP Health Services (a division of Munich American Reassurance Company).
• Hillhouse Capital in its growth equity investment in Arcus Biosciences.
• iLevel Solutions in its merger with Ipreo.
• Level Equity in its growth equity investments in SiteHawk.
• Management of GetWellNetwork in connection with its sale to Pamplona.
• Management of PCI in connection with the sale of PCI to Novocap SAS.
• McCue Corporation in its sale to Eureka.
• TA Associates in its sale of MPI Research to Avista Capital.
• TA Associates in its leveraged buyout of Paula’s Choice.
• TA Associates and its portfolio company, Vatterot College, in its sale and restructuring.